Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.

Luikart SD, Panoskaltsis-Mortari A, Hinkel T, Perri RT, Gupta K, Oegema TR, Gupta P.

BMC Cell Biol. 2009 Aug 28;10:60. doi: 10.1186/1471-2121-10-60.

PMID:
19715605
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.

Luikart SD, Levay-Young B, Hinkel T, Shearer J, Mills C, Caldwell MD, Gyetko MR, Oegema TR.

Wound Repair Regen. 2006 Mar-Apr;14(2):123-8.

PMID:
16630100
[PubMed - indexed for MEDLINE]
3.

Mactinin: a modulator of the monocyte response to inflammation.

Luikart SD, Krug HE, Nelson RD, Hinkel T, Majeski P, Gupta P, Mahowald ML, Oegema T.

Arthritis Res Ther. 2003;5(6):R310-6. Epub 2003 Aug 5.

PMID:
12932295
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications.

Gupta P, LeRoy SC, Luikart SD, Bateman A, Morrison VA.

Leuk Res. 1999 Oct;23(10):953-9.

PMID:
10573142
[PubMed - indexed for MEDLINE]
5.

Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).

Luikart SD, Herndon JE 2nd, Hollis DR, MacDonald M, Maurer LH, Crawford J, Clamon GH, Wright J, Perry MC, Ozer H, Green MR.

Am J Clin Oncol. 1997 Feb;20(1):24-30.

PMID:
9020283
[PubMed - indexed for MEDLINE]
6.

A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B study.

Mitchell EP, Perry MC, Luikart SD, Cirrincione CT, Van Echo DA, Herndon JE 2nd, Maurer LH, Clamon G, Green MR.

Lung Cancer. 1996 Sep;15(2):215-23.

PMID:
8882988
[PubMed - indexed for MEDLINE]
7.

Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines.

Bruno E, Luikart SD, Long MW, Hoffman R.

Exp Hematol. 1995 Oct;23(11):1212-7.

PMID:
7556532
[PubMed - indexed for MEDLINE]
8.

Human bone marrow heparan sulfate induces leukemia cell differentiation.

Luikart SD, Kenney PM, Oegema TR.

Connect Tissue Res. 1995;31(2):99-107.

PMID:
15612325
[PubMed - indexed for MEDLINE]
9.

Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B.

Luikart SD, Goutsou M, Mitchell ED, Van Echo DA, Modeas CR, Propert KJ, O'Donnell J, Difino S, Perry MC, Green MR.

Am J Clin Oncol. 1993 Apr;16(2):127-31.

PMID:
8383914
[PubMed - indexed for MEDLINE]
10.

Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity.

Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM.

Br J Haematol. 1992 May;81(1):27-32.

PMID:
1520621
[PubMed - indexed for MEDLINE]
11.

Bone marrow matrix promotes differentiation and prolongs the cell cycle of U-937 cells.

Hamdan HF, Luikart SD.

Oncol Res. 1992;4(4-5):201-7.

PMID:
1504379
[PubMed - indexed for MEDLINE]
12.

Bone marrow extracellular matrix induces HL-60 cells to produce an autonomous differentiation factor.

Mane S, Winkelmann JC, Luikart SD.

Cell Growth Differ. 1991 Dec;2(12):637-43.

PMID:
1809376
[PubMed - indexed for MEDLINE]
Free Article
13.

Corynebacterium JK: a new pathogen in ventriculostomy infections.

Morrison VA, Weinshel EL, Luikart SD.

J Neurooncol. 1991 Aug;11(1):65-9.

PMID:
1919648
[PubMed - indexed for MEDLINE]
14.

BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis.

Uhlman DL, Verfaillie C, Jones RB, Luikart SD.

Br J Haematol. 1991 Jul;78(3):304-9.

PMID:
1873217
[PubMed - indexed for MEDLINE]
15.

The effect of transforming growth factor-beta 1 on glycosaminoglycan production by human marrow cultures.

Uhlman DL, Mooradian DL, Furcht LT, Luikart SD.

Exp Hematol. 1990 Nov;18(10):1121-5.

PMID:
2120082
[PubMed - indexed for MEDLINE]
16.

A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro.

Luikart SD, Maniglia CA, Furcht LT, McCarthy JB, Oegema TR Jr.

Cancer Res. 1990 Jun 15;50(12):3781-5.

PMID:
2140291
[PubMed - indexed for MEDLINE]
Free Article
17.

Serum and urine glycosaminoglycans in myeloid leukemia and myelodysplasia.

Luikart SD, Fosdick L, Ogle KM, Peterson BA, Bloomfield CD.

Leukemia. 1989 Jan;3(1):48-50.

PMID:
2909808
[PubMed - indexed for MEDLINE]
18.

BCNU-induced increase in sulfated glycosaminoglycan production by human bone marrow stromal cells.

Ogle KM, Luikart SD.

Exp Hematol. 1988 Aug;16(7):636-40.

PMID:
3134251
[PubMed - indexed for MEDLINE]
19.

Degradation of cartilage proteoglycans by myeloid leukemia cells.

Luikart SD.

Exp Hematol. 1988 Feb;16(2):102-5.

PMID:
3276541
[PubMed - indexed for MEDLINE]
20.

Effects of extracellular matrix on the malignant phenotype.

Luikart SD.

Yale J Biol Med. 1988 Jan-Feb;61(1):35-8. Review.

PMID:
3284211
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk